Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
Pharmaceutical · page 9
- CBD Market
HEXO looking to shrink its footprint
FOOTPRINT Hexo closing Belleville facility Approximately 230 employees will be impacted by Quebec-based Hexo’s latest announcement that it is closing its Belleville, Ontario cannabis facility this summer, per Toronto Star.
- Pharmaceutical
Lending company listed as cannabis banking tech award finalist
The company provides compliant banking and financial services to the growing US cannabis industry.
- Pharmaceutical
Former GSK director joins cannabis company
Bill Purves has joined Brains Bioceutical as chief commercial officer.
- Pharmaceutical
OCT’s 8 Board Members Survive Vote To Oust Them As CEO Denounces ‘Scaremongering’
Oxford Cannabinoid Technologies’ (OCT) shareholders have voted to keep all eight of its current directors, following calls from its co-founder to oust them.
- CBD Market
CBD Industry Welcomes FSA’s Public List As ‘Milestone Moment’ Bringing Much Needed ‘Clarity’ To Sector – But Questions Remain Over Its Handling Of The Process
LAST week saw the highly anticipated publication of the Food Standards Agency’s (FSA) Public List, including 3536 CBD products which will now legally be allowed to remain on sale in the UK.
- CBD Market
Mixed response from CBD industry to publication of FSA product list
The development has been described as both a “milestone” and a “monumental waste of time and money”.
- CBD Market
European Round-Up: Germany’s Decriminalisation Delay ‘Incomprehensible’, Maltese Doctor Charged With Drug Trafficking, $100m UK Cannabis Investment et al…
DESPITE being one of the key policies of the ‘Traffic-Light’ German Government do not expect cannabis legalisation to be enacted quickly, says the Minister responsible for its implementation.
- Pharmaceutical
DLA Piper advises on £80m acquisition
Canaccord Genuity was advised on Summerway Capital Plc’s AIM listing.
- Pharmaceutical
OCP reports neuropathic progress in pre-clinical trials
Promising results reported from studies testing the efficacy of its lead compound.
- Pharmaceutical
Oxford Cannabinoid Technologies Releases Update On Its Two Lead Compounds
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased to present an update on the development of its two lead compounds.
- Cultivation
How low are industry expectations about US legalization?
LOW, LOW, LOW Canadian LPs have low expectations for US legalization The Canadian cannabis industry isn’t holding its breath for a positive outcome looking ahead at this Thursday’s debate and Friday vote on the MORE Act in the House of Representatives, reports Canadian Press.
- Pharmaceutical
Celadon Becomes First UK Cannabis Company To Be Admitted To AIM In 21 Years
CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years.
